Chemical and Computational Methods for the Characterization of Covalent Reactive Groups for the Prospective Design of Irreversible Inhibitors
2014 · Journal of Medicinal Chemistry · 318 citations
https://doi.org/10.1021/jm501412a
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
63
Papers
4.1K
Citations
29
h-index
40
i10-index
Mark E. Flanagan is an academic researcher from Pfizer (United States). The author has contributed to research in topics: Chemical Synthesis and Analysis & Advanced biosensing and bioanalysis techniques & Antibiotic Resistance in Bacteria. The author has an h-index of 29, co-authored 54 publications.
ORCID: 0000-0003-4125-3752https://doi.org/10.1021/jm501412a
https://doi.org/10.1038/s43586-021-00084-5
https://doi.org/10.1002/anie.201915493
Click to start Chat